Patents by Inventor Ting-ni Huang

Ting-ni Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
    Publication number: 20220153687
    Abstract: The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX)/histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders.
    Type: Application
    Filed: March 27, 2020
    Publication date: May 19, 2022
    Applicant: TAIWANJ PHARMACEUTICALS CO., LTD.
    Inventors: Syaulan S. YANG, Yan-feng JIANG, Meng-hsien LIU, Chia-hao CHANG, Hao Shiuan LIU, Ying-chu SHIH, Sheng Hung LIU, Chiung Wen WANG, Ting-ni HUANG
  • Method for enhancing the secretion of GLP-1 using bitter compounds
    Patent number: 9446053
    Abstract: The present invention provides a method for enhancing the secretion of GLP-1 of the intestinal endocrine L-cells using a bitter compound, wherein the bitter compound is a cucurbitane-triterpenoid or allyl isothiocyanate. The bitter compound can regulate the secretion of GLP-1, thus is potentially reliable for the development of medicament or healthy victual.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: September 20, 2016
    Assignee: National Taiwan University
    Inventors: Ching-jang Huang, Yi-ping Pai, Ting-ni Huang
  • METHOD FOR ENHANCING THE SECRETION OF GLP-1 USING BITTER COMPOUNDS
    Publication number: 20140228332
    Abstract: The present invention provides a method for enhancing the secretion of GLP-1 of the intestinal endocrine L-cells using a bitter compound, wherein the bitter compound is a cucurbitane-triterpenoid or allyl isothiocyanate. The bitter compound can regulate the secretion of GLP-1, thus is potentially reliable for the development of medicament or healthy victual.
    Type: Application
    Filed: April 2, 2013
    Publication date: August 14, 2014
    Applicant: National Taiwan University
    Inventors: Ching-jang Huang, Yi-ping Pai, Ting-ni Huang